Template:HSV-1 antiviral treatment: Difference between revisions
(Created page with "''Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible'' *Antiviral drug **Acyclovir 40-80mg/kg PO divided in 3-4 doses for 5-...") |
No edit summary |
||
| Line 3: | Line 3: | ||
**[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days | **[[Acyclovir]] 40-80mg/kg PO divided in 3-4 doses for 5-7 days | ||
***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" /> | ***Can also be used as a cream or oral suspension (swish and swallow)<ref name="Mohan" /> | ||
**Valacyclovir (significantly higher bioavailability than acyclovir) | **[[Valacyclovir]] (significantly higher bioavailability than acyclovir) | ||
**Famciclovir | **[[Famciclovir]] | ||
Revision as of 21:26, 25 April 2016
Treatment does not affect dormant virus in nerve ganglions → recurrent disease remains possible
- Antiviral drug
- Acyclovir 40-80mg/kg PO divided in 3-4 doses for 5-7 days
- Can also be used as a cream or oral suspension (swish and swallow)[1]
- Valacyclovir (significantly higher bioavailability than acyclovir)
- Famciclovir
- Acyclovir 40-80mg/kg PO divided in 3-4 doses for 5-7 days
- ↑ Cite error: Invalid
<ref>tag; no text was provided for refs namedMohan